Skip to content

Altitude Crest Partners Inc. 13F Holdings · last filed Q1 2024

Altitude Crest Partners Inc. reported 30 securities worth $233.59M in its SEC 13F filing for Q1 2024 (period ended 2024-03-31). Top holdings: LEGN (15.67%), DHR (11.62%), BBIO (8.10%). Among its top 25 positions this quarter: 18 new, 2 added, 4 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1LEGNLEGEND BIOTECH CORP$36.6M15.67%652,732Added
2DHRDANAHER CORPORATION$27.1M11.62%108,700Trimmed
3BBIOBRIDGEBIO PHARMA INC$18.9M8.10%612,060Trimmed
4STVNSTEVANATO GROUP S P A$17.7M7.56%550,000New
5APLSAPELLIS PHARMACEUTICALS INC$16.9M7.23%287,277Added
6TMOTHERMO FISHER SCIENTIFIC INC$10.7M4.58%18,400New
7AVBPARRIVENT BIOPHARMA INC$9.9M4.25%555,555New
8GPCRSTRUCTURE THERAPEUTICS INC$8.8M3.76%205,166New
9KNSAKINIKSA PHARMACEUTICALS LTD$7.9M3.38%400,441Trimmed
10JANXJANUX THERAPEUTICS INC$7.3M3.12%193,300New
11LLYELI LILLY & CO$7.2M3.06%9,200New
12BHVNBIOHAVEN LTD$6.5M2.77%118,380New
13IMNMIMMUNOME INC$6.5M2.77%262,284New
14SWTXSPRINGWORKS THERAPEUTICS INC$6.3M2.71%128,842New
15GERNGERON CORP$5.1M2.16%1.5MNew
16ICLRICON PLC$5.0M2.13%14,800New
17MRUSMERUS N V$4.9M2.12%109,837New
18ROIVROIVANT SCIENCES LTD$4.8M2.05%454,766Trimmed
19DNLIDENALI THERAPEUTICS INC$4.3M1.84%209,613New
20CRBPCORBUS PHARMACEUTICALS HLDGS$4.1M1.74%103,703New
21AGIOAGIOS PHARMACEUTICALS INC$3.3M1.42%113,100New
22DAWNDAY ONE BIOPHARMACEUTICALS I$3.2M1.38%195,497New
23ALGSALIGOS THERAPEUTICS INC$2.8M1.19%2.8MHold
24ENGNENGENE HOLDINGS INC$2.0M0.87%120,289New
25APLTAPPLIED THERAPEUTICS INC$1.8M0.76%259,700New

Source: SEC Form 13F filings · as of 2024-03-31

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR